The regulation of the immune response in the gut-draining lymph nodes was also affected by the MLT treatment of colitis, with an important increase in the frequency of regulatory T cells, despite a reduced CD3+CD4+ population producing the suppressor cytokine IL-10 (Figure 3A and Supplementary Figure S2). Here, CD4 is linked to colitis.